18F-FES PET/CT检测复发性和转移性乳腺癌的诊断准确性
本研究回顾性纳入162例雌激素受体(ER)阳性乳腺癌患者,评估18F-FES PET/CT对远处转移或复发的诊断价值。患者水平总体灵敏度95%(95%CI 89%-98%)、特异度89%(95%CI 76%-96%)。区域分析中18F-FES PET/CT检出率显著高于标准影像(92% vs 83%,P<0.001)。
要点
- 18F-FES PET/CT诊断ER阳性乳腺癌复发或转移的总体灵敏度95%、特异度89%。
- 复发设置下灵敏度95%、特异度96%;远处转移设置下灵敏度94%、特异度82%。
- 区域检出率18F-FES PET/CT 92% vs 标准影像83%,差异显著(P<0.001)。
核心结论
- 18F-FES PET/CT在疑似新发转移或复发的ER阳性乳腺癌患者中显示出优异的诊断性能。
研究设计与样本
- 回顾性识别自本院一项18F-FES上市后监测前瞻性队列中ER阳性乳腺癌且疑似新发转移或复发的患者。
- 以病理或至少6个月随访的2种及以上标准影像检查为参考标准,评估患者水平诊断准确性。
- 共纳入162例患者,其中疑似复发104例、疑似新发转移58例。
主要发现
- 总体灵敏度95%(95%CI 89%-98%),特异度89%(95%CI 76%-96%)。
- 复发设置下灵敏度95%(95%CI 88%-99%),特异度96%(95%CI 78%-100%)。
- 远处转移设置下灵敏度94%(95%CI 81%-99%),特异度82%(95%CI 60%-95%)。
- 区域分析中18F-FES PET/CT总体检出率92%(95%CI 89%-94%)vs 标准影像83%(95%CI 79%-87%),P<0.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the diagnostic value of 16α- 18 F-fluoro-17β-fluoroestradiol ( 18 F-FES) PET/CT for distant metastasis or recurrence in patients with estrogen receptor (ER)-positive breast cancer. METHODS: Patients with ER-positive breast cancer and suspected of de novo metastasis or recurrence were retrospectively identified from a prospective cohort enrolled for a postmarketing surveillance study of 18 F-FES at our institution. Per-patient diagnostic accuracy was assessed using pathology or 2 or more standard-of-care imaging procedures with a minimum of 6 months of follow-up as the reference standard. The per-region detection rate of 18 F-FES PET/CT was evaluated and compared with that of standard-of-care imaging. RESULTS: Of the 162 included patients, 104 and 58 were suspected to have recurrence or de novo metastasis, respectively. The overall sensitivity and specificity of 18 F-FES PET/CT were 95% (95% confidence interval [CI], 89%-98%) and 89% (95% CI, 76%-96%), respectively. When stratified according to clinical settings, the sensitivity and specificity were 95% (95% CI, 88%-99%) and 96% (95% CI, 78%-100%), respectively, for detecting recurrence, and 94% (95% CI, 81%-99%) and 82% (95% CI, 60%-95%) for detecting distant metastasis. In region-based analysis, the overall detection rate of 18 F-FES PET/CT was significantly higher than that of standard-of-care imaging (92% [95% CI, 89%-94%] vs 83% [95% CI, 79%-87%], P < 0.001). CONCLUSIONS: 18 F-FES PET/CT showed excellent diagnostic performance in patients with ER-positive breast cancer suspected of de novo metastasis or recurrence.
引用
- Shin E, Han S, Ryu J, et al. Diagnostic Accuracy of 18 F-FES PET/CT for the Detection of Recurrent and Metastatic Breast Cancer. Clin Nucl Med. 2024. PMID: 39385365. doi:10.1097/RLU.0000000000005447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。